ERAS vs FTRE Stock Comparison

FTRE currently leads ERAS in this stock comparison, with AIQ scores of 75 vs 61. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 14 points
ERAS
Healthcare
vs
FTRE
Healthcare
ERAS
Erasca, Inc.
Price
$15.66
Day move
-0.76%
AIQ Score
61/100
Best edge
Balanced
Sector
Healthcare
FTRE
Fortrea Holdings Inc.
Leads
Price
$20.20
Day move
+0.7%
AIQ Score
75/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between ERAS and FTRE?

FTRE leads the current stock comparison as Fortrea Holdings Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Erasca, Inc. vs Fortrea Holdings Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 60/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

FTRE leads

FTRE leads by 14 AIQ points, primarily on Momentum, but the lead has narrowed from 36 points over 30 sessions.

Competitive: 3 of 4 evidence groups support FTRE, its lead is narrowing, and its signal state is cleanly positive.

Evidence agreement: 3 of 4Comparison trend: Weakening
ERAS

Erasca, Inc.

AIQ Score
61/100
AIQ Edge Score
10/10
FTRE

Fortrea Holdings Inc.

Leads
AIQ Score
75/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors FTRE over ERAS, 75 versus 61 as of Nov 15, 2026. FTRE's advantage is driven primarily by stronger momentum. FTRE also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor FTRE today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. FTRE lead: Weakening — the AIQ differential moved from 36 to 14 points over 30 sessions.

Compare Erasca, Inc. and Fortrea Holdings Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ERAS
+467.4%
FTRE
-45.2%

Price return comparison

Growth of $10,000, price only

ERAS $56,739 · FTRE $5,483

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ERAS and FTRE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ERAS advantage
0
FTRE advantage
  • Momentum67 vs 88
    FTRE +21
  • Risk Resilience39 vs 41
    Even
  • Quality65 vs 65
    Even

3 of 4 evidence groups favor FTRE. FTRE’s edge is concentrated in momentum.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ERAS+9 AIQ

Largest factor move: Quality +21

New signals

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.70x)
FTRE+1 AIQ

Largest factor move: Quality +1

New signals

  • ADX Trend Weakening — neutral, trend, medium horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-10.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

FTRE's lead narrowed by 8 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — ERAS and FTRE both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

FTRE

FTRE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

FTRE

FTRE on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

FTRE

FTRE on the Momentum factor, by 21 points.

Lower downside

FTRE

FTRE carries the lower 1-month annualized volatility.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureERASFTRENote
Implied upside to target—+22.5%Level
Target dispersion—+30.3%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering915Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor FTRE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreFTRE61 vs 75
FundamentalsFTRErevenue growth 0% vs 2%; EPS growth -7.1% vs 104.5%; operating margin 0% vs 1.6%
ValuationNot coveredNot covered
TechnicalsFTREPrice vs 50-day 4.7% vs -2.7%; vs 200-day 2.6% vs 27%
Risk ResilienceEvenRisk Resilience 39 vs 41
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ERAS and FTRE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 14 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has swung materially session to session. (argues the conclusion is provisional)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on FTRE.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

FTRE lead: Weakening — the AIQ differential moved from 36 to 14 points over 30 sessions.

May 27ERAS leads above the line · FTRE leads belowNov 13
Today
FTRE +14
61 vs 75
7 sessions ago
FTRE +23
51 vs 74
30 sessions ago
FTRE +36
41 vs 77
90 sessions ago
FTRE +16
59 vs 75

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ERASConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only ERAS

  • Death Cross Active — bearish, trend, long horizon (2.00%)
  • Accumulation Pattern — bullish, volume, medium horizon (1.70x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
FTRE

4 bullish / 0 bearish / 2 neutral

Only FTRE

  • Golden Cross Active — bullish, trend, long horizon (30.57%)
  • OBV Bullish Divergence — bullish, volume, medium horizon (-10.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: ADX Trend Weakening, ATR Expansion - Breakout Mode.

ERAS is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ERASDivergence

Price is down while the AIQ Score moved up 9 points over the same session — price and model disagree (price -0.76%, AIQ +9 points).

FTREConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.7%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ERAS closes the Momentum gap — currently 21 points behind, the largest single contributor to FTRE's edge.
  2. 2ERAS's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3FTRE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4The narrowing continues — the lead has already given back 22 points over 30 sessions, and a further 14-point move would eliminate FTRE's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

FTRE leads on balance
MetricERASFTRE
Revenue growth (YoY)0%2%
EPS growth (YoY)-7.1%104.5%
Gross margin0%18.5%
Operating margin0%1.6%
Return on equity (TTM)-5.6%0.1%
Debt to equity0.052.1

Performance

ERAS leads 5 of 6 windows
MetricERASFTRE
1 week (5 sessions)8.7%-8%
1 month (20 sessions)17%-10.2%
3 months (63 sessions)-14.3%11.6%
6 months (126 sessions)53.1%47.9%
Year to date321%17.1%
1 year (252 sessions)490.9%78.1%

Technicals

FTRE has the stronger structure
MetricERASFTRE
RSI (14)53.843.5
ADX (14)11.624.4
Price vs 50-day4.7%-2.7%
Price vs 200-day2.6%27%
Volatility (1M, annualized)81.1%73.4%

Risk

Split
MetricERASFTRE
Beta1.621.62
Sharpe ratio2.291.29
Sortino ratio3.652.02
Max drawdown-59.5%-51.8%
Current drawdown-30.3%-21.9%
Annualized volatility102.7%67.3%
Value at risk (95%)-6.6%-6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ERAS or FTRE?

On the Algovestiq AIQ Score, FTRE is the stronger of the two as of Nov 15, 2026, scoring 75 against ERAS's 61. The edge comes from momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ERAS or FTRE the better buy right now?

FTRE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor FTRE over ERAS?

The composite weights Quality, Value, Momentum and Risk Resilience. FTRE leads Momentum by 21 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ERAS or FTRE?

Analyst price targets imply not covered upside for ERAS and +22.5% for FTRE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ERAS or FTRE?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ERAS or FTRE?

FTRE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ERAS or FTRE?

FTRE on the Momentum factor, by 21 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ERAS or FTRE?

FTRE is the more resilient of the two, so the other name carries the higher downside risk. FTRE carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ERAS more profitable than FTRE?

FTRE leads on the comparable margin measures — gross margin 0% vs 18.5%; operating margin 0% vs 1.6%; ttm roe -5.6% vs 0.1%.

Is FTRE's lead over ERAS getting stronger or weaker?

FTRE lead: Weakening — the AIQ differential moved from 36 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ERAS vs FTRE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ERAS closes the Momentum gap — currently 21 points behind, the largest single contributor to FTRE's edge; ERAS's Death Cross Active resolves — a bearish trend rule currently active against it; FTRE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 22 points over 30 sessions, and a further 14-point move would eliminate FTRE's advantage entirely.

What do the current signals say about ERAS and FTRE?

ERAS: 2 bullish / 2 bearish / 2 neutral, conflicted. FTRE: 4 bullish / 0 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ERAS is Death Cross Active (bearish, long horizon). On FTRE it is Golden Cross Active (bullish, long horizon).

Compare ERAS and FTRE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.